Paper2736709
Potentiation of antimetabolite antitumor activity in vivo by dipyridamole and amphotericin B.
Cao SS and 1 other. Cancer Chemother Pharmacol, 1989. Cited by 72 papers, by iCite.
Cite this record
ConductScience Library. Potentiation of antimetabolite antitumor activity in vivo by dipyridamole and amphotericin B. Papers, record 2736709. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2736709
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Potentiation of antimetabolite antitumor activity in vivo by dipyridamole and amphotericin B.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amphotericin B | Major topic |
| Antimetabolites, Antineoplastic | Major topic |
| Dipyridamole | Major topic |
| Animals | |
| Drug Evaluation, Preclinical | |
| Drug Synergism | |
| Drug Therapy, Combination | |
| Female | |
| Fluorouracil | |
| Lung Neoplasms | |
| Male | |
| Methotrexate | |
| Mice | |
| Mice, Inbred C57BL | |
| Neoplasm Transplantation | |
| Sarcoma 180 | |
| Uterine Cervical Neoplasms |
Source PubMed
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4038918 | Sequence-dependent synergism between dichloromethotrexate and cisplatin in a human colon carcinoma cell line. | Cancer Treat Rep | 1985 | https://conductscience.org/library/papers/4038918 | PubMed |
| 2 | 272228 | Clinical, biological, and biochemical effect of pyrazofurin. | Cancer Res | 1978 | https://conductscience.org/library/papers/272228 | PubMed |
| 3 | 5899044 | [A comparison of the destructive effects of five antitumour agents on various normal tissues in mice]. | Yao Xue Xue Bao | 1965 | https://conductscience.org/library/papers/5899044 | PubMed |
| 4 | 3778458 | Amphotericin B renders stationary phase hepatoma cells sensitive to dipyridamole. | Biochem Biophys Res Commun | 1986 | https://conductscience.org/library/papers/3778458 | PubMed |
| 5 | 6305486 | Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. Clowes Memorial Lecture. | Cancer Res | 1983 | https://conductscience.org/library/papers/6305486 | PubMed |
| 6 | 3542142 | Advances in rational combination chemotherapy. | Cancer Invest | 1986 | https://conductscience.org/library/papers/3542142 | PubMed |
| 7 | 6119898 | Chemotherapeutic inhibitors of the enzymes of the de novo pyrimidine pathway. | Adv Pharmacol Chemother | 1981 | https://conductscience.org/library/papers/6119898 | PubMed |
| 8 | 3673709 | Salvage pathways as targets of chemotherapy. | Adv Enzyme Regul | 1987 | https://conductscience.org/library/papers/3673709 | PubMed |
| 9 | 6243243 | Phase II study of 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC No. 409962) with amphotericin B in bronchogenic carcinoma. | Cancer | 1980 | https://conductscience.org/library/papers/6243243 | PubMed |
| 10 | 19971022 | Response of the Gastrointestinal Tract of the Mouse to 5-Fluorouracil. | Am J Pathol | 1963 | https://conductscience.org/library/papers/19971022 | PubMed |
| 11 | 7396898 | Amphotericin B (Fungizone R) enhancement of nitrogen mustard uptake by human tumor cells. | Biochem Biophys Res Commun | 1980 | https://conductscience.org/library/papers/7396898 | PubMed |
| 12 | 6744269 | Enhancement of the sensitivity of human colon cancer cells to growth inhibition by acivicin achieved through inhibition of nucleic acid precursor salvage by dipyridamole. | Cancer Res | 1984 | https://conductscience.org/library/papers/6744269 | PubMed |
| 13 | 4016741 | Mechanism of synergy between N-phosphonacetyl-L-aspartate and dipyridamole in a human ovarian carcinoma cell line. | Cancer Res | 1985 | https://conductscience.org/library/papers/4016741 | PubMed |
| 14 | 6825115 | Effects of amphotericin B on adriamycin and melphalan cytotoxicity in human and murine ovarian carcinoma and in L1210 leukemia. | Cancer Res | 1983 | https://conductscience.org/library/papers/6825115 | PubMed |
| 15 | 6586287 | Potentiation of methotrexate toxicity by dipyridamole. | Cancer Res | 1984 | https://conductscience.org/library/papers/6586287 | PubMed |
| 16 | 7060316 | Dipyridamol kinetics. | Clin Pharmacol Ther | 1982 | https://conductscience.org/library/papers/7060316 | PubMed |
| 17 | 277727 | Growth and rejection of leukemia cells in individual mice after combined treatment with amphotericin B and 1,3-bis(2-chloroethyl)-1-nitrosourea. | J Natl Cancer Inst | 1978 | https://conductscience.org/library/papers/277727 | PubMed |
| 18 | 3675621 | Amphotericin B: a biological response modifier in targeting against the salvage pathways. | Biochem Pharmacol | 1987 | https://conductscience.org/library/papers/3675621 | PubMed |
| 19 | 6443595 | Salvage capacity of hepatoma 3924A and action of dipyridamole. | Adv Enzyme Regul | 1983 | https://conductscience.org/library/papers/6443595 | PubMed |
| 20 | 6589439 | Amphotericin B potentiation of the cytotoxicity of anticancer agents against both normal hematopoietic and leukemia cells in mice. | J Natl Cancer Inst | 1984 | https://conductscience.org/library/papers/6589439 | PubMed |
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 72 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41565692 | Antigen cross-presentation potentiating cancer vaccine adjuvant for T cell expansion and synergy with anti-PD-1. | NPJ Vaccines | 2026 | https://conductscience.org/library/papers/41565692 | PubMed |
| 37138847 | Synergistic antitumor activity of regorafenib and rosuvastatin in colorectal cancer. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37138847 | PubMed |
| 37026480 | Diverse targets of SMN2-directed splicing-modulating small molecule therapeutics for spinal muscular atrophy. | Nucleic Acids Res | 2023 | https://conductscience.org/library/papers/37026480 | PubMed |
| 36963401 | Targeting the mevalonate pathway suppresses ARID1A-inactivated cancers by promoting pyroptosis. | Cancer Cell | 2023 | https://conductscience.org/library/papers/36963401 | PubMed |
| 36382671 | Potential role of the bitter taste receptor T2R14 in the prolonged survival and enhanced chemoresponsiveness induced by apigenin. | Int J Oncol | 2023 | https://conductscience.org/library/papers/36382671 | PubMed |
| 36189423 | Functional high-throughput screen identifies microRNAs that promote butyrate-induced death in colorectal cancer cells. | Mol Ther Nucleic Acids | 2022 | https://conductscience.org/library/papers/36189423 | PubMed |
| 35835838 | Co-inhibition of ATM and ROCK synergistically improves cell proliferation in replicative senescence by activating FOXM1 and E2F1. | Commun Biol | 2022 | https://conductscience.org/library/papers/35835838 | PubMed |
| 35456598 | NMS-873 Leads to Dysfunctional Glycometabolism in A p97-Independent Manner in HCT116 Colon Cancer Cells. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35456598 | PubMed |
| 35118769 | An oral first-in-class small molecule RSK inhibitor suppresses AR variants and tumor growth in prostate cancer. | Cancer Sci | 2022 | https://conductscience.org/library/papers/35118769 | PubMed |
| 34899683 | Pharmacological Poly (ADP-Ribose) Polymerase Inhibitors Decrease Mycobacterium tuberculosis Survival in Human Macrophages. | Front Immunol | 2021 | https://conductscience.org/library/papers/34899683 | PubMed |
| 34493732 | Targeting the IRE1α/XBP1s pathway suppresses CARM1-expressing ovarian cancer. | Nat Commun | 2021 | https://conductscience.org/library/papers/34493732 | PubMed |
| 33562636 | Integrative Transcriptomic Network Analysis of Butyrate Treated Colorectal Cancer Cells. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33562636 | PubMed |
| 33388950 | Pingyangmycin enhances the antitumor efficacy of anti-PD-1 therapy associated with tumor-infiltrating CD8+ T cell augmentation. | Cancer Chemother Pharmacol | 2021 | https://conductscience.org/library/papers/33388950 | PubMed |
| 33203790 | Silencing KIF14 reverses acquired resistance to sorafenib in hepatocellular carcinoma. | Aging (Albany NY) | 2020 | https://conductscience.org/library/papers/33203790 | PubMed |
| 33115525 | Ascorbic acid (vitamin C) synergistically enhances the therapeutic effect of targeted therapy in chronic lymphocytic leukemia. | J Exp Clin Cancer Res | 2020 | https://conductscience.org/library/papers/33115525 | PubMed |
| 32575795 | Treatment with a New Barbituric Acid Derivative Exerts Antiproliferative and Antimigratory Effects against Sorafenib Resistance in Hepatocellular Carcinoma. | Molecules | 2020 | https://conductscience.org/library/papers/32575795 | PubMed |
| 32433558 | Stress-induced TRAILR2 expression overcomes TRAIL resistance in cancer cell spheroids. | Cell Death Differ | 2020 | https://conductscience.org/library/papers/32433558 | PubMed |
| 31950222 | Enhanced anticancer activity of combined treatment of imatinib and dipyridamole in solid Ehrlich carcinoma-bearing mice. | Naunyn Schmiedebergs Arch Pharmacol | 2020 | https://conductscience.org/library/papers/31950222 | PubMed |
| 31289488 | Ampelopsin-sodium induces apoptosis in human lung adenocarcinoma cell lines by promoting tubulin polymerization in vitro. | Oncol Lett | 2019 | https://conductscience.org/library/papers/31289488 | PubMed |
| 29920512 | Systems modelling of the EGFR-PYK2-c-Met interaction network predicts and prioritizes synergistic drug combinations for triple-negative breast cancer. | PLoS Comput Biol | 2018 | https://conductscience.org/library/papers/29920512 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2736709
GET https://conductscience.org/api/papers/v1/2736709/references?page=2